Manglam Ultracare Traexim Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.44 Cr
- Revenue Growth 513.05%
- Profit Growth -1424.40%
- Ebitda -502.63%
- Net Worth -66.88%
- Total Assets 107.38%
About Manglam Ultracare Traexim
Manglam Ultracare Traexim Private Limited (MUTPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 March 2015 (Nine years and ten months 18 days old ). Its registered office is in Shajapur, Madhya Pradesh, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.44 Cr.
Parag Agrawal, Manoj Kumar, and Anoop Shukla serve as directors at the Company.
Company Details
-
Location
Shajapur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01100MP2015PTC034032
-
Company No.
034032
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 2015
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Manglam Ultracare Traexim?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Agrawal
|
Director | 07-Jul-2017 | Current |
|
Manoj Kumar
|
Director | 07-Jul-2017 | Current |
|
Anoop Shukla
|
Director | 30-Mar-2015 | Current |
Financial Performance of Manglam Ultracare Traexim.
Manglam Ultracare Traexim Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 513.05% increase. The company also saw a substantial fall in profitability, with a 1424.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 66.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manglam Ultracare Traexim?
In 2019, Manglam Ultracare Traexim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jade Sparrow Private LimitedManoj Kumar and Anoop Shukla are mutual person
Charges (Loans)
₹2.44 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2021 | Others | ₹1.00 Cr | Open |
| 28 Jul 2020 | Others | ₹3.75 M | Open |
| 27 Sep 2018 | Others | ₹1.06 Cr | Open |
How Many Employees Work at Manglam Ultracare Traexim?
Unlock and access historical data on people associated with Manglam Ultracare Traexim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manglam Ultracare Traexim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manglam Ultracare Traexim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
